ak 2123 has been researched along with fluorouracil in 1 studies
| Studies (ak 2123) | Trials (ak 2123) | Recent Studies (post-2010) (ak 2123) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 52 | 8 | 5 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | ak 2123 (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iakushchenko, TN; Kagiia, T; Konovalova, NP; Kotel'nikova, RA; Tat'ianenko, LV; Volkova, LM | 1 |
1 other study(ies) available for ak 2123 and fluorouracil
| Article | Year |
|---|---|
[Inhibitory effect of the radiosensitizer AK-2123 on experimental liver metastasis and active transport of calcium ions].
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Calcium Channel Blockers; Female; Fluorouracil; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiation-Sensitizing Agents; Time Factors; Triazoles | 1997 |